Overview

Hepatocellular Carcinoma (HCC)_Torisel_

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a phase I/II study to evaluate dose limited toxicity and efficacy of Torisel
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Everolimus
Sirolimus